Influenza viral particles harboring the SARS-CoV-2 spike RBD as a combination respiratory disease vaccine
R. R. Chaparian, A. T. Harding, K. Riebe, A. Karlsson, G. D. Sempowski, N. S. Heaton, B. E. Heaton
This paper develops a combination vaccine using recombinant influenza A virus to deliver SARS-CoV-2 spike RBD, showing protection against both pathogens.
bioRxiv · Apr 30, 2021 · PreprintMicrobiology